Industry Hails Access Implications As FTC Promises PBM Probe
Follows AAM And Biosimilars Forum’s Calls For Action Over Behaviors That Restrict Access
Industry is hoping the inquiry could help unlock access to generics and biosimilars • Source: Shutterstock 
